发明名称 AIRWAY ADMINISTRATION OF ANGIOGENESIS INHIBITORS
摘要 <p>The present invention provides methods for the local pulmonary treatment of lung metastases and/or primary lung cancer, such as squamous lung cancer and/or small cell lung cancer, using local deposition of one or more agents capable of inhibiting angiogenesis and/or an agent that acts as an active anti-cancer agent and/or an active anti-metastatic agent. The agent capable of inhibiting angiogenesis and/or which acts as an active anti-cancer agent and/or an active anti-metastatic agent is administered to a patient with cancer as a treatment of said metastasis and/or cancer or to extend the lifespan for said cancer patient with reduced systemic side- effects compared to other treatment forms. The agent capable of inhibiting angiogenesis and/or which acts as an active anti-cancer agent and/or an active anti- metastatic agent is administered intratracheal, intrabronchial, intraalveolar or broncioalveolar. Administration for example via inhalation of an aerosol or as a dry powder and/or administered as a bronchoalveolar lavage (BAL) an effective amount of the agent.</p>
申请公布号 SG188401(A1) 申请公布日期 2013.04.30
申请号 SG20130016241 申请日期 2011.09.09
申请人 TRIFOILIUM APS 发明人 HESLET, LARS;FIALA, KAARE
分类号 主分类号
代理机构 代理人
主权项
地址